Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Hollander

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Retina (Philadelphia, Pa.)|October 20, 2004
Distinguishing features of nontraumatic and traumatic retinal dialysesDavid A Hollander, Alexander R Irvine, Antony M Poothullil, et al.
American Journal of Ophthalmology|May 9, 2006
Bacterial endophthalmitis after resident-performed cataract surgeryDavid A Hollander, M Reza Vagefi, Stuart R Seiff, et al.
Advances in Therapy|March 12, 2013
Ocular surface tolerability of prostaglandin analogs and prostamides in patients with glaucoma or ocular hypertensionAndrew C S Crichton, Steven Vold, Julia M Williams, et al.
International Journal of Inflammation|October 11, 2013
Inflammation in retinal diseaseScott M Whitcup, Robert B Nussenblatt, Susan L Lightman, et al.
The Ocular Surface|January 18, 2016
Effects of Punctal Occlusion on Clinical Signs and Symptoms and on Tear Cytokine Levels in Patients with Dry EyeLouis Tong, Roger Beuerman, Susan Simonyi, et al.
Ophthalmic Plastic and Reconstructive Surgery|August 16, 2003
Re: Traumatic evulsion of the globeDavid A Hollander, Jay M Stewart, Dan D DeAngelis, et al.
Therapeutics and Clinical Risk Management|November 2, 2013
Health claims database study of cyclosporine ophthalmic emulsion treatment patterns in dry eye patientsKarl G Stonecipher, Jenny Chia, Ahunna Onyenwenyi, et al.
Clinical Ophthalmology (Auckland, N.Z.)|April 7, 2011
Ex vivo corneal epithelial wound healing following exposure to ophthalmic nonsteroidal anti-inflammatory drugsKeping Xu, Mark McDermott, Linda Villanueva, et al.
Current Medical Research and Opinion|May 28, 2009
Safety and tolerability of brimonidine purite 0.1% and brimonidine purite 0.15%: a meta-analysis of two phase 3 studiesLouis B Cantor, Ching-Chi Liu, Amy L Batoosingh, et al.
American Journal of Ophthalmology|November 9, 2004
The pseudopapilledema of neonatal-onset multisystem inflammatory diseaseDavid A Hollander, William F Hoyt, Edward L Howes, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Retina (Philadelphia, Pa.)|October 20, 2004
Distinguishing features of nontraumatic and traumatic retinal dialysesDavid A Hollander, Alexander R Irvine, Antony M Poothullil, et al.
American Journal of Ophthalmology|May 9, 2006
Bacterial endophthalmitis after resident-performed cataract surgeryDavid A Hollander, M Reza Vagefi, Stuart R Seiff, et al.
Advances in Therapy|March 12, 2013
Ocular surface tolerability of prostaglandin analogs and prostamides in patients with glaucoma or ocular hypertensionAndrew C S Crichton, Steven Vold, Julia M Williams, et al.
International Journal of Inflammation|October 11, 2013
Inflammation in retinal diseaseScott M Whitcup, Robert B Nussenblatt, Susan L Lightman, et al.
The Ocular Surface|January 18, 2016
Effects of Punctal Occlusion on Clinical Signs and Symptoms and on Tear Cytokine Levels in Patients with Dry EyeLouis Tong, Roger Beuerman, Susan Simonyi, et al.
Ophthalmic Plastic and Reconstructive Surgery|August 16, 2003
Re: Traumatic evulsion of the globeDavid A Hollander, Jay M Stewart, Dan D DeAngelis, et al.
Therapeutics and Clinical Risk Management|November 2, 2013
Health claims database study of cyclosporine ophthalmic emulsion treatment patterns in dry eye patientsKarl G Stonecipher, Jenny Chia, Ahunna Onyenwenyi, et al.
Clinical Ophthalmology (Auckland, N.Z.)|April 7, 2011
Ex vivo corneal epithelial wound healing following exposure to ophthalmic nonsteroidal anti-inflammatory drugsKeping Xu, Mark McDermott, Linda Villanueva, et al.
Current Medical Research and Opinion|May 28, 2009
Safety and tolerability of brimonidine purite 0.1% and brimonidine purite 0.15%: a meta-analysis of two phase 3 studiesLouis B Cantor, Ching-Chi Liu, Amy L Batoosingh, et al.
American Journal of Ophthalmology|November 9, 2004
The pseudopapilledema of neonatal-onset multisystem inflammatory diseaseDavid A Hollander, William F Hoyt, Edward L Howes, et al.
Pageof 8